z-logo
open-access-imgOpen Access
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland
Author(s) -
Anna Baraniak,
Radosław Izdebski,
M. Herda,
Janusz Fiett,
Waleria Hryniewicz,
Marek Gniadkowski,
Izabela Kern-Zdanowicz,
K Filczak,
Urszula Łopaciuk
Publication year - 2009
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.00436-09
Subject(s) - klebsiella pneumoniae , outbreak , microbiology and biotechnology , klebsiella infections , klebsiella , antibiotic resistance , biology , antibiotics , virology , escherichia coli , biochemistry , gene
Plasmidic KPC β-lactamases in gram-negative pathogens are of the highest clinical and epidemiologic concern, conferring resistance to all β-lactams, including carbapenems (15, 18). The main KPC producer is Klebsiella pneumoniae, but other species are being identified as well (15). Strains with KPCs spread rapidly and cause outbreaks; in hospitals on the east coast of the United States and in Israel, they have already become endemic (2, 3, 10, 14, 17). Recently, more countries have reported the presence of these organisms, in some cases as a result of importation (15).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom